TP53TG1/STAT axis is involved in the development of colon cancer through affecting PD-L1 expression and immune escape mechanism of tumor cells

被引:0
|
作者
Ji, Wenmin [1 ,3 ]
Wang, Wenyan [2 ]
Wei, Yanfang [1 ]
机构
[1] Shanxi Med Univ, Hosp 1, Taiyuan 030001, Shanxi, Peoples R China
[2] Shanxi Inst Food & Drug Control, Taiyuan 030001, Shanxi, Peoples R China
[3] Shanxi Med Univ, Hosp 1, 85 Jiefang South Rd, Taiyuan 030000, Shanxi, Peoples R China
来源
AMERICAN JOURNAL OF CANCER RESEARCH | 2023年 / 13卷 / 11期
关键词
PD-1/PD-L1; TP53TG1; immune escape; STAT pathway; colon cancer; REGULATORY T-CELLS; LONG NONCODING RNA; CD8(+) T; IMMUNOTHERAPY; COMBINATION; THERAPY; TARGET; RESISTANCE; PROGNOSIS; CD4(+);
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This research is dedicated to investigating the mechanism of programmed cell death ligand 1 (PD-L1) and tumor protein 53 target gene 1 (TP53TG1) in immune regulation of colon cancer (CC). Expressions of TP53TG1, PDL1 and signal transducers and activators of transcription (STATs) in CC and their correlation were detected through bioinformatics analysis. Effects of PD-L1 and TP53TG1 on the CC were assessed by in vivo and in vitro experiments. Herein, PD-L1 level was negatively correlated with TP53TG1 expression, but was positively correlated with the levels of STATs. Both overexpressed TP53TG1 and PD-L1 antibody reversed the effects of CT26 cells on inhibiting cell proliferation, cytokine secretion and PD-L1 level, and enhancing the cytotoxicity of NK cells and CD8+ T cells. TP53TG1 reduced PD-L1 level by inactivating STATs pathway. Downregulation of PD-L1 increased cytokine secretion and T lymphocyte killing ability, promoted tumor cell apoptosis, and inhibited the tumor growth. Altogether, TP53TG1/STAT axis regulates the immunomodulatory mechanism of CC by reducing PD-L1 expression.
引用
收藏
页码:5218 / +
页数:19
相关论文
共 50 条
  • [21] Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
    Blank, C
    Gajewski, TF
    Mackensen, A
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (04) : 307 - 314
  • [22] Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
    Christian Blank
    Thomas F. Gajewski
    Andreas Mackensen
    Cancer Immunology, Immunotherapy, 2005, 54 : 307 - 314
  • [23] Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis
    Huang, Yusheng
    Xia, Lei
    Tan, Xiangwu
    Zhang, Jingyi
    Zeng, Weiwei
    Tan, Benxu
    Yu, Xian
    Fang, Wei
    Yang, Zhenzhou
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2022, 27 (01)
  • [24] Mechanism of the KIAA1429/KLF1/PD-L1 Axis in Regulating Immune Escape in Non-small Cell Lung Cancer
    Geng, Rui
    Ren, Mingmin
    Ma, Yuhui
    Su, Wen
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, : 1835 - 1845
  • [25] c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis
    Zhang, Lan
    Wang, Xiaohui
    Li, Yunfei
    Han, Jing
    Gao, Xianzheng
    Li, Shenglei
    Wang, Feng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (09):
  • [26] HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma
    Cheng, Hongxia
    Wang, Sikai
    Huang, Aidan
    Ma, Jing
    Gao, Dongmei
    Li, Miaomiao
    Chen, Huaping
    Guo, Kun
    CANCER BIOLOGY & THERAPY, 2023, 24 (01) : 1 - 9
  • [27] Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients
    Weyerer, Veronika
    Strissel, Pamela L.
    Strick, Reiner
    Sikic, Danijel
    Geppert, Carol I.
    Bertz, Simone
    Lange, Fabienne
    Taubert, Helge
    Wach, Sven
    Breyer, Johannes
    Bolenz, Christian
    Erben, Philipp
    Schmitz-Draeger, Bernd J.
    Wullich, Bernd
    Hartmann, Arndt
    Eckstein, Markus
    CANCERS, 2021, 13 (10)
  • [28] Upregulation of Immune checkpoint PD-L1 in Colon cancer cell lines and activation of T cells by Leuconostoc mesenteroides
    Altves, Safaa
    Guclu, Ebru
    Yetisgin, Esra
    Bilecen, Kivanc
    Vural, Hasibe
    WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2024, 40 (07)
  • [29] Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression
    Xu, Pengfei
    Xiong, Wei
    Lin, Yun
    Fan, Liping
    Pan, Hongchao
    Li, Yaochen
    CELL DEATH & DISEASE, 2021, 12 (08)
  • [30] Circular RNA hsa_circ_0067842 facilitates tumor metastasis and immune escape in breast cancer through HuR/CMTM6/PD-L1 axis
    Juan Li
    Xiangjun Dong
    Xue Kong
    Yafen Wang
    Yanru Li
    Yao Tong
    Wenjing Zhao
    Weili Duan
    Peilong Li
    Yanqun Wang
    Chuanxin Wang
    Biology Direct, 18